Company Intelligence
Insilico Medicine
Insilico Medicine provides enterprise-grade artificial intelligence solutions, delivering specialized Insilico Medicine Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Hong Kong, Hong Kong
- Website
- insilico.com
- Founded
- 2014
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Insilico Medicine is a Healthcare AI company based in Hong Kong, Hong Kong, founded in 2014.
Clinical-stage generative AI biotechnology company advancing Rentosertib and a broad AI-discovered pipeline.
Verified founder profile on Brel: Alex Zhavoronkov.
What it builds
Insilico Medicine Platform
Why It Matters
Insilico Medicine provides enterprise-grade artificial intelligence solutions, delivering specialized Insilico Medicine Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Insilico Medicine — Biotechnology
Explore Insilico Medicine — Biotechnology by Insilico Medicine. Verified AI product intelligence covering core capabilities, Healthcare use cases,…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Insilico Medicine
Industry
Industries served
- Biotechnology
Products
Technologies
Capabilities
Insilico's generative chemistry creates novel molecular structures optimized for developability, not just scoring existing libraries. PandaOmics integrates literature, patents, causal networks, and…
Features
Pharma.AI platform spanning PandaOmics target discovery, Chemistry42 generative chemistry, and clinical development tools — plus an internal pipeline of AI-originated drug candidates…
Integrations
- PandaOmics integrates literature
- patents
- causal networks
- aging hallmarks to rank targets such as TNIK for fibrosis.
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Frequently Asked Questions
What does Insilico Medicine do?
Insilico Medicine specializes in artificial intelligence, developing Insilico Medicine Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Insilico Medicine based and when was it founded?
Insilico Medicine is based in Hong Kong and was founded in 2014.
What are the main products offered by Insilico Medicine?
The flagship platform from Insilico Medicine is Insilico Medicine Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Insilico Medicine?
Insilico Medicine primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.